Early Biomarkers and Hearing Impairments in Patients with Neonatal Hypoxic–Ischemic Encephalopathy

Identifying biomarkers for hearing impairments (HIs) in patients with neonatal hypoxic–ischemic encephalopathy (HIE), to initialize early hearing habilitation, is crucial. Seventy-eight neonates with HIE were divided into the following two groups: those with HIs and those without HIs. We compared th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Da-Yang, Lee, Inn-Chi, Wang, Xing-An, Wong, Swee-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620896/
https://www.ncbi.nlm.nih.gov/pubmed/34829404
http://dx.doi.org/10.3390/diagnostics11112056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620896/
https://www.ncbi.nlm.nih.gov/pubmed/34829404
http://dx.doi.org/10.3390/diagnostics11112056

Ejemplares similares